Abstract
Rubinstein–Taybi syndrome (RSTS) is a well-known autosomal dominant mental retardation syndrome with typical facial and skeletal abnormalities. Previously, we have reported two patients presenting with RSTS and additional clinical features including failure to thrive, seizures, and intractable infections (Bartsch et al. in Eur J Hum Genet 7:748–756, 1999). Recently we identified a third patient with this condition, termed here severe RSTS, or chromosome 16p13.3 deletion syndrome. The three patients died in infancy, and all displayed a specific mutation, a chromosomal microdeletion including the 3′-end of the CREBBP gene. Using fluorescence in situ hybridization and closely spaced DNA probes, we characterized the deletion intervals in these patients and in three individuals with a deletion of CREBBP and typical RSTS. The deleted DNA segments were found to greatly vary in size, spanning from ∼40 kb to >3 Mb. Four individuals, including the patients with severe RSTS, exhibited deletions containing gene/s in addition to CREBBP. The patients with severe RSTS all had deletions comprising telomeric neighbor genes of CREBBP, including DNASE1, a dominant gene encoding a nuclease that has been associated with systemic lupus erythematodes. Our findings suggest that severe RSTS is distinct from RSTS and represents a novel true contiguous gene syndrome (chromosome 16p13.3 deletion syndrome). Because of the risk of critical infections and high mortality rate, we recommend that the size of the deletion interval should be determined in CREBBP deletion-positive patients with RSTS, especially in young children. Further studies are needed to delineate the clinical spectrum of the new disorder and to clarify the role of DNASE1.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bartsch O, Wagner A, Hinkel GK, Krebs P, Stumm M, Schmalenberger B, Böhm S, Balci S, Majewski F (1999) FISH studies in 45 patients with Rubinstein–Taybi syndrome: deletions associated with polysplenia, hypoplastic left heart and death in infancy. Eur J Hum Genet 7:748–756
Bartsch O, Locher K, Meinecke P, Kress W, Seemanová E, Wagner A, Ostermann K, Rödel G (2002) Molecular studies in 10 cases of Rubinstein–Taybi syndrome, including a mild variant showing a missense mutation in codon 1175 of CREBBP. J Med Genet 39:496–501
Bartsch O, Schmidt S, Richter M, Morlot S, Seemanová E, Wiebe G, Rasi S (2005) DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein–Taybi syndrome (RSTS) and in another patient with incomplete RSTS. Hum Genet 117:485–493
Breuning MH, Dauwerse HG, Fugazza G, Saris JJ, Spruit L, Wijnen H, Tommerup N, van der Hagen CB, Imaizumi K, Kuroki Y, van den Boogaard MJ, de Pater JM, Mariman ECM, Hamel BCJ, Himmelbauer H, Frischauf AM, Stallings RL, Beverstock GC, van Ommen GJB, Hennekam RCM (1993) Rubinstein–Taybi syndrome caused by submicroscopic deletions within 16p13.3. Am J Hum Genet 52:249–254
Cotsirilos P, Taylor JC, Matalon R (1987) Dominant inheritance of a syndrome similar to Rubinstein–Taybi. Am J Med Genet 26:85–93
Coupry I, Roudaut C, Stef M, Delrue MA, Marche M, Burgelin I, Taine L, Cruaud C, Lacombe D, Arveiler B (2002) Molecular analysis of the CBP gene in 60 patients with Rubinstein–Taybi syndrome. J Med Genet 39:416–421
Coupry I, Monnet L, Attia AA, Taine L, Lacombe D, Arveiler B (2004) Analysis of CBP (CREBBP) gene deletions in Rubinstein–Taybi syndrome patients using real-time quantitative PCR. Hum Mutat 23:278–284
Felts SJ, Owen BAL, Nguyen PM, Trepel J, Donner DB, Toft DO (2000) The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties. J Biol Chem 275:3305–3312
Hanauer D, Argilla M, Wallerstein R (2002) Rubinstein–Taybi syndrome and hypoplastic left heart. Am J Med Genet 112:109–111
Hendrich B, Bickmore W (2001) Human diseases with underlying defects in chromatin structure and modification. Hum Mol Genet 10:2233–2242
Hennekam RC, Stevens CA, Van de Kamp JJ (1990) Etiology and recurrence risk in Rubinstein–Taybi syndrome. Am J Med Genet Suppl 6:56–64
Imaizumi K, Kuroki Y (1991) Rubinstein–Taybi syndrome with de novo reciprocal translocation t(2;16)(p13.3;p13.3). Am J Med Genet 38:636–639
Kimura H, Ito Y, Koda Y, Hase Y (1993) Rubinstein–Taybi syndrome with thymic hypoplasia. Am J Med Genet 46:293–296
Petrij F, Giles RH, Dauwerse HG, Saris JJ, Hennekam RCM, Masuno M, Tommerup N, van Ommen G-JB, Goodman RH, Peters DJM, Breuning MH (1995) Rubinstein–Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376:348–351
Petrij F, Dauwerse HG, Blough RI, Giles RH, van der Smag JJ, Wallerstein R, Maaswinkel-Mooy PD, van Karnebeek CD, van Ommen GJ, van Haeringen A, Rubinstein JH, Saal HM, Hennekam RC, Peters DJM, Breuning MH (2000) Diagnostic analysis of the Rubinstein–Taybi syndrome: five cosmids should be used for microdeletion detection and low number of protein truncation mutations. J Med Genet 37:168–176
Roelfsema JH, White SJ, Ariyürek Y, Bartholdi D, Niedrist D, Papadia F, Bacino CA, den Dunnen JT, van Ommen GJB, Breuning MH, Hennekam RC, Peters DJM (2005) Genetic heterogeneity in Rubinstein–Tyabi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet 76:572–580
Rubinstein JH (1990) Broad thumb-hallux (Rubinstein–Taybi) syndrome 1957–1988. Am J Med Genet Suppl 6:3–16
Solomou EE, Juang YT, Gourley MF, Kammer GM, Tsokos GC (2001) Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus. J Immunol 166:4216–4222
Stevens CA, Bhakta MG (1995) Cardiac abnormalities in the Rubinstein–Taybi syndrome. Am J Med Genet 59:346–348
Wiley S, Swayne S, Rubinstein JH, Lanphear NE, Stevens CA (2003) Rubinstein–Taybi syndrome medical guidelines. Am J Med Genet 119A:101–110
Yasutomo K, Horiuchi T, Kagami S, Tsukamoto H, Hashimura C, Urushihara M, Kuroda Y (2001) Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 28:313–314
Zhu G, Bartsch O, Skrypnyk C, Rotondo A, Akhtar LA, Harris C, Virkkunen M, Cassano G, Goldman D (2004) Failure to detect DUP25 in lymphoblastoid cells derived from patients with panic disorder and control individuals representing European and American populations. Eur J Hum Genet 12:505–508
Acknowledgments
We would like to thank the patients and their families for contributing this study, Corinna Menzel, Max Planck Institute for Molecular Genetics, Berlin, Germany, for technical assistance, Dr. Renata Gaillyová, University Children’s Hospital Brno Bohunice, Czech Republic, for clinical data of patient 3, and Mrs. Rachel Pettman, IWK Health Centre, Halifax, NS, Canada for genetic counselling of patient 6. This work was supported in part by a grant (Ba-1397/5-1) from the Deutsche Forschungsgemeinschaft.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bartsch, O., Rasi, S., Delicado, A. et al. Evidence for a new contiguous gene syndrome, the chromosome 16p13.3 deletion syndrome alias severe Rubinstein–Taybi syndrome. Hum Genet 120, 179–186 (2006). https://doi.org/10.1007/s00439-006-0215-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-006-0215-0